Literature DB >> 19351922

Drugging the Wnt pathway: problems and progress.

Ken Garber.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19351922     DOI: 10.1093/jnci/djp084

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  18 in total

Review 1.  Targeted therapies for adrenocortical carcinoma: IGF and beyond.

Authors:  Michael J Demeure; Kimberly J Bussey; Lawrence S Kirschner
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

Review 2.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

Review 3.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.

Authors:  William Hankey; Wendy L Frankel; Joanna Groden
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

4.  Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes.

Authors:  Sujatha Muralidharan; Patrick J Hanley; Enli Liu; Rikhia Chakraborty; Catherine Bollard; Elizabeth Shpall; Cliona Rooney; Barbara Savoldo; John Rodgers; Gianpietro Dotti
Journal:  J Immunol       Date:  2011-10-19       Impact factor: 5.422

Review 5.  Tackling the cancer stem cells - what challenges do they pose?

Authors:  Diwakar R Pattabiraman; Robert A Weinberg
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

6.  Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.

Authors:  Wen Zhang; Vitaliy Sviripa; Liliia M Kril; Xi Chen; Tianxin Yu; Jiandang Shi; Piotr Rychahou; B Mark Evers; David S Watt; Chunming Liu
Journal:  J Med Chem       Date:  2011-02-03       Impact factor: 7.446

7.  AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition.

Authors:  Hannah A Scarborough; Barbara A Helfrich; Matias Casás-Selves; Alwin G Schuller; Shaun E Grosskurth; Jihye Kim; Aik-Choon Tan; Daniel C Chan; Zhiyong Zhang; Vadym Zaberezhnyy; Paul A Bunn; James DeGregori
Journal:  Clin Cancer Res       Date:  2016-09-23       Impact factor: 12.531

Review 8.  Modulating the stem cell niche for tissue regeneration.

Authors:  Steven W Lane; David A Williams; Fiona M Watt
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

9.  Current and emerging therapeutic options in adrenocortical cancer treatment.

Authors:  Antonio Stigliano; Lidia Cerquetti; Camilla Sampaoli; Barbara Bucci; Vincenzo Toscano
Journal:  J Oncol       Date:  2012-08-14       Impact factor: 4.375

10.  Targeting self-renewal pathways in myeloid malignancies.

Authors:  William A Sands; Mhairi Copland; Helen Wheadon
Journal:  Cell Commun Signal       Date:  2013-05-15       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.